Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Current Assets (2016 - 2026)

Orthopediatrics has reported Current Assets over the past 11 years, most recently at $245.9 million for Q1 2026.

  • For Q1 2026, Current Assets rose 5.95% year-over-year to $245.9 million; the TTM value through Mar 2026 reached $245.9 million, up 5.95%, while the annual FY2025 figure was $256.4 million, 8.11% up from the prior year.
  • Current Assets for Q1 2026 was $245.9 million at Orthopediatrics, down from $256.4 million in the prior quarter.
  • Over five years, Current Assets peaked at $257.7 million in Q2 2025 and troughed at $131.4 million in Q1 2022.
  • A 5-year average of $220.7 million and a median of $226.5 million in 2023 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: decreased 13.55% in 2022 and later skyrocketed 71.18% in 2023.
  • Year by year, Current Assets stood at $226.7 million in 2022, then dropped by 0.1% to $226.5 million in 2023, then increased by 4.71% to $237.2 million in 2024, then rose by 8.11% to $256.4 million in 2025, then fell by 4.12% to $245.9 million in 2026.
  • Business Quant data shows Current Assets for KIDS at $245.9 million in Q1 2026, $256.4 million in Q4 2025, and $245.9 million in Q3 2025.